Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Speaking of 7, this has been the very first time that RNVA has had 7 consecutive weekly closes at .0001. Having said that, I expect it will close at .000001 next week however, I believe a run will happen before the end of the month (jmho or same 'ol wishful thinking).
11.88 finally! Let the climb continue.💲
Wil you please tell that to the CEO. Tell him he can start now. He ain't gotta buy it all at once, just a bit at a time.
😀.0024 now in less than 10 minutes. 🚀😃
Yep, movin' fast here.
.0023's on deck!
Good Mornin' 💲ABQQ💲. Bring on that 8k. Looking forward to some upward movement this week.
Exactly. Chart is ready for a big run.
The timing of the X post is perfect imo.
Awesome, entertaining post JD! Copper this week perhaps?
💲VLCN💲 The SQEEZE is on!
Nice action here. In @ .146 avg. GO $$VLCN$$
Bbbbut I was taught dat gawd made erbody and erthing, and he sent DT to save us too. He made peeps with deformities come in all differences, derrr. Oh yeah, and he made da devil too, and french fries. He making stocks too? Love thy neighbor as you love french fries.
💲 GO ABQQ 💲🚀
On the move breaking through barriers today.
💲Oversold & ready to bounce.💲
I'm ready to grab more ABQQ today.
It's all good. Got my coffee cup in hand & looking forward to a fine day of trading.
That video was a rude awakening so early in the morning. Ughh, where's my coffee 😒
Thanks. Good video.
Moooovin' on UP!🚀
Gearing up for a good run tomorrow
That's what I thought, but it actually hit .0024 today. Buckle up for tomorrow's ride!
Thanks. I wish I could get more today but gotta wait till tomorrow.
OMG! I just got some this a.m. for .0018! What a nice surprise to see it at .0021 already!
SAVE on the move!$$$$$
You're right though. This board is surprisingly quiet.
I gotta think there's more here who just ain't posting. I don't post on all boards I'm in either.
Airship AI Highlights
Large and Rapidly Growing Size of Addressable Market
$7 billion edge AI software and hardware addressable market today, projected to grow to over $40 billion in 20301.
This growth is expected to be driven by strong demand for AI solutions in public safety, industrial, and logistics settings.
Differentiated End-to-End Solution
Airship AI leverages AI at the edge to help improve public safety and operational efficiency for public sector and commercial customers by providing predictive analysis of events before they occur and meaningful intelligence to decision makers.
Solutions work with clients’ existing hardware and capitalize on rapidly growing use of AI to create efficiency, increase speed, reduce costs, and improve decision-making.
Blue-Chip Customer Base
Existing customers include federal government agencies across the Department of Homeland Security, Department of Justice, Department of Defense, and Intelligence Community, along with state and local law enforcement agencies and Fortune 500 companies FedEx and Home Depot.
In December 2023 began delivery of multiple firm fixed price contracts worth $10.9 million, awarded in September 2023 by an agency within the Department of Homeland Security (DHS), for advanced integrated solutions supporting real-time intelligence collection operations along the United States’ borders, leveraging the Company’s edge IoT appliance, Outpost AI.
Strong Growth with Software Margin
2022A: $14.5 million revenue, 57.9% gross margin, positive EBITDA.
NTM (Next Twelve Months, which denotes July 1, 2023 - June 30, 2024 forecast period): $39 million revenue, 65% gross margin, $9 million EBITDA.
Opportunity for margin expansion with recently launched Edge products.
Visible and Robust Pipeline
Strong pipeline predominantly with the U.S. government in addition to new growth opportunities within the commercial sector
💲8+
Here we go!
And it's still in oversold territory with lots of room to run.
And it was around 40 before the Amazon acquisition was announced. It fell way too far due to that recent EU news. Bounce imminent imo.
Grabbed some. Been waiting all month for this to start moving up before getting in.
"JetBlue and Spirit appeal judge’s ruling that blocks their proposed merger."
https://www.cnbc.com/2024/01/19/jetblue-and-spirit-appeal-judges-ruling-that-blocks-their-proposed-merger.html
Here comes the bounce. AH it should continue up.
And still climbing. What a beast!
Here's Why Grifols (GRFS) is Poised for a Turnaround After Losing -31.55% in 4 Weeks
https://finance.yahoo.com/news/heres-why-grifols-grfs-poised-143503975.html?.tsrc=rss
It's waay oversold btw.
GRFS headed up! - Plasma donations dropped during the pandemic and now recovering. Very lucrative business been around since 1940.
"Grifols SA has an analyst consensus of Moderate Buy, with a price target consensus of $16.26, representing an 89.5% upside. In a report issued on January 4, Barclays also upgraded the stock to Buy with a EUR18.00 price target."
Chart concurs with those price targets by the way.
https://markets.businessinsider.com/news/stocks/analysts-are-bullish-on-these-healthcare-stocks-nyxoah-nyxh-grifols-sa-grfs-1032962325
Plasma donations dropped drastically during the pandemic and is now recovering.
The plasma industry is a very lucrative business which pays the donors $30 - $50 for 880ml of plasma if not donated for free. That same 880ml bottle is then sold to biotechs for $1,000+ for R&D and manufacturing of pharmaceutical products. This company was founded in 1940 and is involved in all aspects of plasma - from donation centers to final products.
"The company's products and services are used by healthcare providers to diagnose and treat patients with hemophilia, immune deficiencies, infectious diseases, and other medical conditions. Grifols, S.A. has collaboration agreements with Canadian Blood Services for the processing of other plasma-derived products, and with GIANT and GigaGen to develop recombinant polyclonal immunoglobulin therapies."
https://www.marketbeat.com/stocks/NASDAQ/GRFS/